ArticleBMC psychiatry2025
Neural association between mental symptoms and facial emotion recognition in deficit schizophrenia: an fNIRS study.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe dysfunction of the prefrontal cortex (PFC) is closely related to the emotion recognition deficits in schizophrenia. Compared with the non-deficit schizophrenia (NDSZ), deficit schizophrenia (DSZ) has a more severe deficit in emotion recognition; however, the underlying neurobiological mechanism is unclear. Thus, this study aimed to investigate PFC activation patterns and their correlations with clinical scale scores during facial emotion recognition (FER) between the DSZ and NDSZ using functional near-infrared spectroscopy (fNIRS).
methodsThis study included 38 DSZ patients, 49 NDSZ patients, and 39 healthy controls (HCs). FER was evaluated using a standardized visual emotion discrimination task, while PFC activation was monitored via fNIRS. To identify channels(CHs) with statistically significant differences in oxygenated hemoglobin (HbO) changes across the three groups, we performed one-way ANOVA followed by post hoc Bonferroni tests for pairwise comparisons. These analyses explored the relationship between HbO concentration changes in the PFC and clinical scale scores during FER tasks.
resultsDuring anger, sadness, contempt, and happiness recognition tasks, the DSZ group showed significantly reduced HbO activation in the dorsolateral prefrontal cortex (DlPFC; Brodmann area 9, BA9) and the frontopolar cortex(BA10), compared with the NDSZ group. Similarly, decreased activation patterns were observed in BA9 and BA10 in the DSZ group during anger and happiness recognition tasks compared with the HCs. Furthermore, during contempt recognition, reduced activation was found in BA9 compared with the HCs. Correlation analyses revealed moderate negative associations (i.e., an inverse relationship) between activation levels in these prefrontal regions (BA9/BA10) and negative symptoms (i.e., diminution of emotional expression and motivation) scores in DSZ patients across these four emotion tasks. However, no significant correlations were found in NDSZ patients and HCs.
conclusionCompared with the NDSZ patients, DSZ patients exhibited more severe FER impairments, demonstrating a different cognitive deficit pattern. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.